CEP97 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.68158845023936E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.01590000248331E-08 |
Normal-vs-Stage2 |
1.00599999997009E-06 |
Normal-vs-Stage3 |
1.62120317170888E-11 |
Normal-vs-Stage4 |
2.67199999903767E-08 |
Stage1-vs-Stage2 |
2.735600E-01 |
Stage1-vs-Stage3 |
1.491960E-02 |
Stage1-vs-Stage4 |
1.164780E-01 |
Stage2-vs-Stage3 |
5.088000E-01 |
Stage2-vs-Stage4 |
8.279600E-01 |
Stage3-vs-Stage4 |
6.462200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.82750497962547E-11 |
Normal-vs-AfricanAmerican |
7.4741002276113E-10 |
Normal-vs-Asian |
5.696200E-01 |
Caucasian-vs-AfricanAmerican |
2.304000E-02 |
Caucasian-vs-Asian |
8.037600E-02 |
AfricanAmerican-vs-Asian |
8.359400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.90114632106997E-13 |
Normal-vs-Female |
1.47439999986787E-07 |
Male-vs-Female |
3.360200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.170600E-04 |
Normal-vs-Age(41-60Yrs) |
6.10829999914131E-08 |
Normal-vs-Age(61-80Yrs) |
6.56419363309624E-12 |
Normal-vs-Age(81-100Yrs) |
1.73299996575338E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.751400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.816400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.436300E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.214000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.236430E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.698500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.689030E-01 |
Normal-vs-Grade 2 |
1.62339999998373E-07 |
Normal-vs-Grade 3 |
2.86959345174864E-12 |
Normal-vs-Grade 4 |
1.9082999624942E-09 |
Grade 1-vs-Grade 2 |
2.450200E-01 |
Grade 1-vs-Grade 3 |
2.867800E-02 |
Grade 1-vs-Grade 4 |
1.988360E-02 |
Grade 2-vs-Grade 3 |
2.031900E-02 |
Grade 2-vs-Grade 4 |
3.488000E-02 |
Grade 3-vs-Grade 4 |
5.905400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.37719999995889E-06 |
Normal-vs-ccB subtype |
1.2496004231366E-10 |
ccA subtype-vs-ccB subtype |
1.121970E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.42089995325279E-09 |
Normal-vs-N1 |
1.309590E-02 |
N0-vs-N1 |
8.763200E-01 |
|
|